Edwards Lifesciences Reports First Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
Edwards Lifesciences (EW) Tops Q1 EPS by 8c; Boosts FY14 EPS Midpoint
April 23, 2015 4:57 PM EDTEdwards Lifesciences (NYSE: EW) reported Q1 EPS of $1.12, $0.08 better than the analyst estimate of $1.04. Revenue for the quarter came in at $590.3 million versus the consensus estimate of $585.16 million.
Edwards Lifesciences sees FY2015 EPS of $4.10-$4.30, versus prior guidance of $4.00-$4.30 and the consensus of $4.21.... More



